Heart check for new Weight-Loss drug: does it pass the test?
NCT ID NCT06200467
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study checked whether the experimental drug survodutide (BI 456906) causes any heart rhythm changes in 110 adults with overweight or obesity. Participants received weekly injections of survodutide or a placebo for about 30 weeks, along with a single dose of moxifloxacin (a drug known to affect heart rhythm) to compare results. The goal was to ensure the drug is safe for the heart before further development.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.